Allogeneic Cell Therapy Bioprocess Economics and Optimization: Single-Use Cell Expansion Technologies

For allogeneic cell therapies to reach their therapeutic potential, challenges related to achieving scalable and robust manufacturing processes will need to be addressed. A particular challenge is producing lot-sizes capable of meeting commercial demands of up to 10(9) cells/dose for large patient n...

Descripción completa

Detalles Bibliográficos
Autores principales: Simaria, Ana S, Hassan, Sally, Varadaraju, Hemanthram, Rowley, Jon, Warren, Kim, Vanek, Philip, Farid, Suzanne S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065358/
https://www.ncbi.nlm.nih.gov/pubmed/23893544
http://dx.doi.org/10.1002/bit.25008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065358/
https://www.ncbi.nlm.nih.gov/pubmed/23893544
http://dx.doi.org/10.1002/bit.25008

Ejemplares similares